BitMine Immersion doubles down on Ethereum, amassing 163,000 ETH days after $250 million PIPE raise
Quick Take BitMine has acquired over 163,000 ETH, worth more than double the proceeds of its $250 million PIPE raise. The company says it aims to grow its ether treasury via capital markets and staking while supporting Ethereum’s decentralization.
NYSE-listed BitMine Immersion Technologies said Monday it now holds nearly $500 million worth of ether as the bitcoin-miner-turned-treasury-vehicle accelerates its pivot to an Ethereum-centric balance-sheet strategy.
The Nevada-based firm disclosed that it amassed over 163,000 ETH since its initial capital raise, spending double the $250 million generated from share sales. The purchase lifts BitMine’s reported stash above the 160,142, cementing it as one of the largest public holders of the asset and ranking it second among Ethereum treasuries, per DefiLlama. Only the Ethereum Foundation and SharpLink boast bigger ETH reserves.
BitMine (ticker BMNR) adopted an "asset-light" treasury model in June, pledging to increase ether held per share through capital-markets activity, staking yields, and reinvested operating cash flow. The firm's stock surged 400% as management said the strategy will both enhance shareholder value and support Ethereum’s decentralization by removing supply from circulation.
Board chairman and Fundstrat founder, Tom Lee, likened the approach to Strategy’s high-profile bitcoin play, arguing that large corporate treasuries can create a reflexive benefit as institutional demand grows. He said Strategy's 597,000 BTC trove has formed a "sovereign put" for nation-states to access bitcoin exposure.
"Similarly, ETH Treasuries, which accumulate 5% of ETH supply, can benefit from a similar 'Wall Street put’," Lee noted. BitMine has indicated it may continue tapping capital markets to enlarge its position, but did not outline further purchase targets.
Shares of BMNR rose 15% in Monday's session while ether changed hands around $3,066, up almost 3% in 24 hours, according to The Block’s ETH price page .
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

